1. |
Ronco C, Di Lullo L. Cardiorenal syndrome. Heart Fail Clin, 2014, 10(2): 251-280.
|
2. |
Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol, 2008, 52(19): 1527-1539.
|
3. |
Hatamizadeh P, Fonarow GC, Budoff MJ, et al. Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol, 2013, 9(2): 99-111.
|
4. |
Pimienta González R, Couto Comba P, Rodríguez Esteban M, et al. Incidence, mortality and positive predictive value of type 1 cardiorenal syndrome in acute coronary syndrome. PLoS One, 2016, 11(12): e0167166.
|
5. |
Ronco C, Di Lullo L. Cardiorenal syndrome in western countries: epidemiology, diagnosis and management approaches. Kidney Dis (Basel), 2017, 2(4): 151-163.
|
6. |
Xu J, Jiang W, Fang Y, et al. Management of cardiac surgery-associated acute kidney injury. Contrib Nephrol, 2016, 187: 131-142.
|
7. |
Hou FF, Yang X. Advances in the management of acute cardiorenal syndrome in China: biomarkers for predicting development and outcomes. Kidney Dis (Basel), 2017, 2(4): 145-150.
|
8. |
Cheng H, Chen YP. Clinical prediction scores for type 1 cardiorenal syndrome derived and validated in Chinese cohorts. Cardiorenal Med, 2015, 5(1): 12-19.
|
9. |
Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation, 2006, 113(5): 671-678.
|
10. |
Braam B, Joles JA, Danishwar AH, et al. Cardiorenal syndrome-current understanding and future perspectives. Nat Rev Nephrol, 2014, 10(1): 48-55.
|
11. |
Parikh CR, Mansour SG. Perspective on clinical application of biomarkers in AKI. J Am Soc Nephrol, 2017, 28(6): 1677-1685.
|
12. |
Wang Y, Zou Z, Jin J, et al. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery. BMC Nephrol, 2017, 18(1): 177.
|
13. |
Jiang W, Teng J, Xu J, et al. Dynamic predictive scores for cardiac surgery-associated acute kidney injury. J Am Heart Assoc, 2016, 5(8): e003754.
|
14. |
Ronco C, Kaushik M, Valle R, et al. Diagnosis and management of fluid overload in heart failure and cardio-renal syndrome: the " 5B” approach. Semin Nephrol, 2012, 32(1): 129-141.
|
15. |
Kim DH, Chien FJ, Eisen HJ. Pharmacologic management for heart failure and emerging therapies. Curr Cardiol Rep, 2017, 19(10): 94.
|
16. |
Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol, 2005, 46(11): 2043-2046.
|
17. |
Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol, 2007, 49(6): 675-683.
|
18. |
Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med, 2012, 367(24): 2296-2304.
|
19. |
Kazory A. Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations. Clin J Am Soc Nephrol, 2013, 8(10): 1816-1828.
|
20. |
Writing Committee Members, Yancy CW, Jessup M, et al. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation, 2016, 134(13): e282-e293.
|
21. |
Cho YJ, Lee EH, Lee K, et al. Long-term clinical outcomes of Remote Ischemic Preconditioning and Postconditioning Outcome (RISPO) trial in patients undergoing cardiac surgery. Int J Cardiol, 2017, 231: 84-89.
|
22. |
Premuzic V, Basic-Jukic N, Jelakovic B, et al. Continuous veno-venous hemofiltration improves survival of patients with congestive heart failure and cardiorenal syndrome compared to slow continuous ultrafiltration. Ther Apher Dial, 2017, 21(3): 279-286.
|
23. |
Xu J, Ding X, Fang Y, et al. New, goal-directed approach to renal replacement therapy improves acute kidney injury treatment after cardiac surgery. J Cardiothorac Surg, 2014, 9: 103.
|
24. |
Wu B, Yan W, Li X, et al. Initiation and cessation timing of renal replacement therapy in patients with type 1 cardiorenal syndrome: an observational study. Cardiorenal Med, 2017, 7(2): 118-127.
|
25. |
Xu J, Shen B, Fang Y, et al. Postoperative fluid overload is a useful predictor of the short-term outcome of renal replacement therapy for acute kidney injury after cardiac surgery. Medicine (Baltimore), 2015, 94(33): e1360.
|
26. |
Ezekowitz JA, O’meara E, Mcdonald MA, et al. 2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Can J Cardiol, 2017, 33(11): 1342-1433.
|